[Federal Register Volume 59, Number 157 (Tuesday, August 16, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-19940]
[[Page Unknown]]
[Federal Register: August 16, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Meeting; Forum on Cooperative Research and Development Agreements
Notice is hereby given that a second Forum on Cooperative Research
and Development Agreements (CRADAs), convened as an ad hoc group of
consumer consultants to the Advisory Committee to the Director, NIH,
will meet in public session on September 8, 1994, from 8:30 am to 5:30
pm, at the Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, Maryland,
20814. This Forum is convened in follow-up to a previous Forum on this
topic July 21, 1994.
The purpose of the second Forum is to elicit consumer and other
public interest perspectives which will be used in NIH's development of
policy on the ``reasonable pricing'' clause, which is currently
required in its Cooperative Research and Development Agreements
(CRADAs) under the Federal Technology Transfer Act of 1986 and
exclusive commercialization licenses. The Forum Panel members will
discuss how best to ensure that the public investment in products
developed through licensing NIH technologies is adequately reflected.
Discussion will include an analysis of the clause and the Panel will
advise on whether the clause has been useful to ensure that the public
investment in collaborative research is adequately considered in the
subsequent commercial development of technology arising under such
research.
At the conclusion of the Forum, the Panel will develop and transmit
its report to the Advisory Committee to the Director, NIH, for review.
Concerned organizations and individuals are invited to present
their views at the Forum or submit written views of any length to the
Panel. Please submit requests for a 5 minute presentation time, or
written views to: Ms. Elyssa Tran, Office of Science Policy and
Technology Transfer, National Institutes of Health, Building 1, Room
218, 9000 Rockville Pike, Rockville, MD 20892, (301) 402-0280 (fax).
Written views submitted by September 1 will be distributed to the
Panel. Comments and questions related to the proposed Forum may also be
addressed to Ms. Tran at (301) 496-1454.
Dated: August 8, 1994.
Ruth Kirschstein, M.D.,
Deputy Director, NIH.
[FR Doc. 94-19940 Filed 8-15-94; 8:45 am]
BILLING CODE 4140-01-P
